Cited by 106Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers

Open access
Gendron, Tania F., van Blitterswijk, Marka, Bieniek, Kevin F., Daughrity, Lillian M., Jiang, Jie, Rush, Beth K., Pedraza, Otto, Lucas, John A. +21 more·2015·Acta Neuropathologica

Abstract

Clinical and neuropathological characteristics associated with G4C2 repeat expansions in chromosome 9 open reading frame 72 (C9ORF72), the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, are highly variable. To gain insight on the molecular basis for the heterogeneity among C9ORF72 mutation carriers, we evaluated associations between features of disease and levels of two abundantly expressed "c9RAN proteins" produced by repeat-associated non-ATG (RAN) translation of the expanded repeat. For these studies, we took a departure from traditional immunohistochemical approaches and instead employed immunoassays to quantitatively measure poly(GP) and poly(GA) levels in cerebellum, frontal cortex, motor cortex, and/or hippocampus from 55 C9ORF72 mutation carriers [12 patients with ALS, 24 with frontotemporal lobar degeneration (FTLD) and 19 with FTLD with motor neuron disease (FTLD-MND)]. We additionally investigated associations between levels of poly(GP) or poly(GA) and cognitive impairment in 15 C9ORF72 ALS patients for whom neuropsychological data were available. Among the neuroanatomical regions investigated, poly(GP) levels were highest in the cerebellum. In this same region, associations between poly(GP) and both neuropathological and clinical features were detected. Specifically, cerebellar poly(GP) levels were significantly lower in patients with ALS compared to patients with FTLD or FTLD-MND. Furthermore, cerebellar poly(GP) associated with cognitive score in our cohort of 15 patients. In the cerebellum, poly(GA) levels similarly trended lower in the ALS subgroup compared to FTLD or FTLD-MND subgroups, but no association between cerebellar poly(GA) and cognitive score was detected. Both cerebellar poly(GP) and poly(GA) associated with C9ORF72 variant 3 mRNA expression, but not variant 1 expression, repeat size, disease onset, or survival after onset. Overall, these data indicate that cerebellar abnormalities, as evidenced by poly(GP) accumulation, associate with neuropathological and clinical phenotypes, in particular cognitive impairment, of C9ORF72 mutation carriers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-015-1474-4

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DPR inclusions rarely co-label with TARDBP pathological inclusions and are mainly found in areas of the CNS that are not pathologically affected, arguing against a direct role for DPRs in neurodegeneration.

    “On the other hand, DPR inclusions rarely co-label with TARDBP pathological inclusions and are mainly found in areas of the CNS that are not pathologically affected [171,174–177], arguing against a direct role for DPRs in neurodegeneration.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gendron, T. F., van Blitterswijk, M., Bieniek, K. F., Daughrity, L. M., Jiang, J., Rush, B. K., Pedraza, O., Lucas, J. A., Murray, M. E., Desaro, P., Robertson, A., Overstreet, K., Thomas, C. S., Crook, J. E., Castanedes-Casey, M., Rousseau, L., Josephs, K. A., Parisi, J. E., Knopman, D. S., Petersen, R. C., Boeve, B. F., Graff-Radford, N. R., Rademakers, R., Lagier-Tourenne, C., Edbauer, D., Cleveland, D. W., Dickson, D. W., Petrucelli, L., & Boylan, K. B.
Affiliations
  • Mayo Clinic (US)
  • University of California San Diego (US)
  • Mayo Clinic in Florida (US)
  • German Center for Neurodegenerative Diseases (DE)
Corresponding author
Petrucelli, Leonard
Venue
Acta Neuropathologica
Published
2015-09-08
Volume
130
Issue
4
Pages
559-573
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W1610732998
Cited by
106
References
43
Citations by year
2026: 2 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 6 · 2020: 15 · 2019: 12 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 2
FWCI
9.87
Type
journal article
Language
en
Open access
Locations
  • Acta Neuropathologica (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Institute of Neurological Disorders and Stroke (R21NS089979, R21NS084528, R01NS088689, R01NS063964, R01NS077402, P01NS084974, R01NS080882, F32NS087842)
  • U.S. Department of Defense (ALSRP AL130125)
  • Mayo Foundation for Medical Education and Research
  • Amyotrophic Lateral Sclerosis Association (15-IIP-202, Milton Safenowitz Post Doctoral Fellowship)
  • Target ALS
  • ALS Therapy Alliance
  • Ludwig Institute for Cancer Research
  • Seventh Framework Programme (FP7/2014-2019 grant 617198)
  • Robert Packard Center for ALS
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
C9orf72, G4C2 repeat expansion, repeat-associated non-ATG translation, cerebellum, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, cognitive impairment, disease heterogeneity, neuropathology
MeSH terms
C9orf72 Protein, Aged, Aged, 80 and over, Amyotrophic Lateral Sclerosis, Cerebellum, Cognition Disorders, Female, Frontal Lobe, Heterozygote, Hippocampus, Humans, Male, Middle Aged, Motor Cortex, Proteins, RNA, Messenger, Protein Biosynthesis, Cohort Studies, Motor Neuron Disease, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review